These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 23583976)

  • 1. Role of lipid in forming an infectious prion?
    Wang F; Ma J
    Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):485-93. PubMed ID: 23583976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prion disease and the 'protein-only hypothesis'.
    Ma J; Wang F
    Essays Biochem; 2014; 56():181-91. PubMed ID: 25131595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity.
    Timmes AG; Moore RA; Fischer ER; Priola SA
    PLoS One; 2013; 8(7):e71081. PubMed ID: 23936256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow virus disease: deciphering conflicting data on the transmissible spongiform encephalopathies (TSE) also called prion diseases.
    Bastian FO; Fermin CD
    Microsc Res Tech; 2005 Nov; 68(3-4):239-46. PubMed ID: 16276518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro prion protein conversion suggests risk of bighorn sheep (Ovis canadensis) to transmissible spongiform encephalopathies.
    Morawski AR; Carlson CM; Chang H; Johnson CJ
    BMC Vet Res; 2013 Aug; 9():157. PubMed ID: 23938169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generating Bona Fide Mammalian Prions with Internal Deletions.
    Munoz-Montesino C; Sizun C; Moudjou M; Herzog L; Reine F; Chapuis J; Ciric D; Igel-Egalon A; Laude H; Béringue V; Rezaei H; Dron M
    J Virol; 2016 Aug; 90(15):6963-6975. PubMed ID: 27226369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The scrapie enigma: insights from radiation experiments.
    Alper T
    Radiat Res; 1993 Sep; 135(3):283-92. PubMed ID: 8104352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.
    Simoneau S; Thomzig A; Ruchoux MM; Vignier N; Daus ML; Poleggi A; Lebon P; Freire S; Durand V; Graziano S; Galeno R; Cardone F; Comoy E; Pocchiari M; Beekes M; Deslys JP; Fournier JG
    Virulence; 2015; 6(2):132-44. PubMed ID: 25585171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of prion infectivity and levels of scrapie prion protein by lithium aluminum hydride: implications for RNA in prion diseases.
    Jeong BH; Kim NH; Jin JK; Choi JK; Lee YJ; Kim JI; Choi EK; Carp RI; Kim YS
    J Neuropathol Exp Neurol; 2009 Aug; 68(8):870-9. PubMed ID: 19606066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion protein and scrapie susceptibility.
    Smits MA; Bossers A; Schreuder BE
    Vet Q; 1997 Sep; 19(3):101-5. PubMed ID: 9323849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converting the prion protein: what makes the protein infectious.
    Baskakov IV; Breydo L
    Biochim Biophys Acta; 2007 Jun; 1772(6):692-703. PubMed ID: 16935473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal modes of prion proteins: from native to infectious particle.
    Samson AO; Levitt M
    Biochemistry; 2011 Mar; 50(12):2243-8. PubMed ID: 21338080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of PrP in health and disease.
    Flechsig E; Weissmann C
    Curr Mol Med; 2004 Jun; 4(4):337-53. PubMed ID: 15354865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scrapie prion liposomes and rods exhibit target sizes of 55,000 Da.
    Bellinger-Kawahara CG; Kempner E; Groth D; Gabizon R; Prusiner SB
    Virology; 1988 Jun; 164(2):537-41. PubMed ID: 3130718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion infectivity is encoded exclusively within the structure of proteinase K-resistant fragments of synthetically generated recombinant PrP
    Wang F; Wang X; Abskharon R; Ma J
    Acta Neuropathol Commun; 2018 Apr; 6(1):30. PubMed ID: 29699569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
    Surewicz WK; Jones EM; Apetri AC
    Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of recombinant prion autocatalysis from infectivity.
    Noble GP; Supattapone S
    Prion; 2015; 9(6):405-11. PubMed ID: 26645356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manganese enhances prion protein survival in model soils and increases prion infectivity to cells.
    Davies P; Brown DR
    PLoS One; 2009 Oct; 4(10):e7518. PubMed ID: 19844576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods.
    Shaked GM; Meiner Z; Avraham I; Taraboulos A; Gabizon R
    J Biol Chem; 2001 Apr; 276(17):14324-8. PubMed ID: 11152454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.